|
LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema
RECRUITINGN/ASponsored by University Hospital, Ghent
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital, Ghent
Started2021-06-30
Est. completion2025-12-27
Eligibility
Age18 Years – 99 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05601037
Summary
Lymphedema is defined as a chronic condition, caused by lymphostasis. A major part in the Western world consists of iatrogenic lymphedema caused by surgery to the lymph nodes of the axilla or groin. Prophylactic lymphovenous anastomosis (LVA) could be beneficial in the prevention of lymphedema of the extremities.
Eligibility
Age: 18 Years – 99 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria: * lymph node + breast cancer requiring dissection Exclusion Criteria: * previous lymphedema * BMI \>35
Conditions3
Breast CancerCancerLymphedema, Breast Cancer
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital, Ghent
Started2021-06-30
Est. completion2025-12-27
Eligibility
Age18 Years – 99 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05601037